Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

Saved in:
Bibliographic Details
Title: Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.
Authors: Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Palladini G; University of Pavia and Foundation IRCCS Policlinico San Matteo, Pavia, Italy., Minnema MC; UMC Utrecht, Utrecht, Netherlands., Wechalekar AD; University College London Hospital and National Amyloidosis Center (UCL Royal Free Campus), London, UK, Gower St., United Kingdom., Jaccard A; CHU Limoges, Limoges, France., Lee HC; Sarah Cannon Research Institute, Nashville, Tennessee, United States., Sanchorawala V; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Mollee P; Princess Alexandra Hospital, Brisbane, Australia., Lu J; peking university people's hospital, beijing, China., Schönland SO; Heidelberg University, Heidelberg, Germany., Gatt ME; Hadassah Medical Center, jerusalem, Israel., Suzuki K; Japanese Red Cross Medical Center, tokyo, Japan., Kim K; Samsung Medical Center, Seoul, Korea, Republic of., Cibeira MT; Hospita Clinic de Barcelona, Barcelona, Spain., Bhutani M; Atrium Health Levine Cancer Institute, Charlotte, North Carolina, United States., Beksac M; Istinye University, Ankara, Turkey., Libby EN; Fred Hutchinson Cancer Research Center, San Diego, California, United States., Valent J; Taussig Cancer Institute, Cleveland, Ohio, United States., Hungria V; Clinica São Germano, São Paulo, Brazil., Rosenzweig MA; City of Hope, Duarte, California, United States., Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States., Huart A; University Hospital of Toulouse, Toulouse, France., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Department of Medicine, Korea University, Seoul, Republic of Korea, Athens, Greece., Bhutani D; Columbia University Medical Center, New York, New York, United States., Waxman A; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Goodman S; Vanderbilt University, Nashville, Tennessee, United States., Zonder JA; Karmanos Cancer Institute, Detroit, Michigan, United States., Lam S; London Health Sciences Centre., Song KW; The Vancouver General Hospital, Vancouver, Canada., Hansen T; Onkologicum HOPA, Hamburg, Hamburg, Germany., Manier S; CHU Lille, Lille, France., Roeloffzen WWH; Amyloidosis Centre of Expertise Department of Internal Medicine, Faculty of Medical Sciences, University Medical Center Groningen, Groningen, Netherlands., Jamroziak K; Medical University of Warsaw, Warsaw, Poland., Kwok F; Westmead Hospital, Westmead, Australia., Shimazaki C; Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Kim JS; Yonsei University College of Medicine, Seoul, Korea, Republic of., Crusoé EQ; Hospital Universitário Professor Edgar Santos (HUPES), Universidade Federal da Bahia; Clinica CEHON Rede D'or Oncologia, Salvador, Brazil., Tran N; Janssen Research & Development, LLC, Los Angeles, California, United States., Wang J; Janssen Pharmaceuticals, Belle Mead, New Jersey, United States., Chen Y; Janssen Research & Development, LLC, Shanghai, China., Vasey SY; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Schecter JM; Janssen Research & Development, LLC, Raritan, New Jersey, United States., Vermeulen J; Janssen Research & Development, LLC, Leiden, Netherlands., Comenzo R; Tufts Medical Center, Boston, Massachusetts, United States., Merlini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Source: Blood [Blood] 2026 May 12. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025032099